Overview
Valued at ~$5.6 billion in 2023, the nephrology and urology devices market is projected to reach
~$8.4 billion by 2028, increasing at a CAGR of 8.4% over the 2023-2028 forecast period. This
Market Snapshot is part of LSI’s Market Intelligence platform, your one-stop-shop for global
medtech market sizing and analysis, procedure volume data, startup company- and deal-tracking,
curated insights, and more.
The nephrology and urology devices market encompasses products employed in the diagnosis,
treatment, and management of six major conditions:
End-stage renal disease (ESRD)
Incontinence
Calculi (stones)
Benign prostatic hyperplasia (BPH)
Prostatitis
Erectile dysfunction (ED)
Products included within the scope of this analysis include:
Urine bags
Foley catheters
Catheter insertion kits
Intermittent catheters
Endourology devices
BPH ablation devices
Lithotripsy devices
Artificial penile implants (excluding pelvic floor repair mesh)
Urinary stents
This Market Snapshot is intended to provide an executive overview of the global market for nephrology and
urology devices, with key insights into:
The nephrology and urology devices market encompasses products employed in the diagnosis, treatment, and
management of six major conditions:
Unit volumes from 2023 to 2028
Market forecasts from 2023 to 2028
Market insights
Competitive landscape analysis of major competitors
Insights into key market events for strategic and startups
Nephrology and Urology Devices Market Snapshot Summary
| Report Aspect | Data and Details |
| Base Year for Estimate | 2023 |
| Forecast Period | 2023 - 2028 |
| Market Size in 2023 | $5.6 billion |
| CAGR | 8.4% |
| Projected Market Size in 2028 | $8.4 billion |
Nephrology and Urology Devices Market Insights
The nephrology and urology devices market is primarily driven by three core segments: specialty
urology products, incontinence management, and urine management. Specialty urology products,
such as devices used to treat BPH, are
essential, as BPH affects over 30 million men
globally.
Incontinence management, which addresses the needs of 400-500 million people worldwide, is
another significant market segment, considering the growing aging population. Urine management,
especially in hospital settings, sees high usage, as millions of patients require monitoring for
kidney and bladder function post-operation.
Market growth is attributable to the aging population and the increasing prevalence of
conditions like ESRD, which
affects three million people globally. M&As also play a significant
role, with major players like Teleflex and Boston Scientific making strategic acquisitions to
expand their portfolios. Additionally, there is substantial innovation from startups offering
improved solutions for consumables, such as catheters, which continue to shape the evolving
landscape. The nephrology and urology devices market has seen nearly $900 billion raised from
June of 2023 to October of 2024.
Competitive Landscape
The full Market Snapshot includes a robust analysis of the competitive landscape for the
nephrology and urology devices market. This includes estimated market revenue and market share
for key players, such as Coloplast, BD, and Boston Scientific.
Select Market Events
| Company | Date | Type | Event |
|
Teleflex
|
7/2023 | M&A | Teleflex acquired Palette Life Sciences for $600 million. |
|
Boston Scientific
|
1/2024 | M&A | Boston Scientific acquired Axonics. |
Key Companies Covered
3M Healthcare
Astratech
Aurie
Balton
Baxter Healthcare
B. Braun
BD
Boston Scientific
Coloplast
Cook Medical
EndoMed Hollister
ICU Medical
Karl Storz
Liebel Flarshem
Lumenis Surgical
MedPro
Medtronic
Merit Medical
Nipro
Olympus
PFM Medical
Rethink Medical
Teleflex
Uromed
UroMems
Urovision
Yushin Medical
